Cargando…
Refining a Protocol for Faecal Microbiota Engraftment in Animal Models After Successful Antibiotic-Induced Gut Decontamination
BACKGROUND: There is mounting evidence for the therapeutic use of faecal microbiota transplant (FMT) in numerous chronic inflammatory diseases. Germ free mice are not always accessible for FMT research and hence alternative approaches using antibiotic depletion prior to FMT in animal studies are oft...
Autores principales: | Amorim, Nadia, McGovern, Emily, Raposo, Anita, Khatiwada, Saroj, Shen, Sj, Koentgen, Sabrina, Hold, Georgina, Behary, Jason, El-Omar, Emad, Zekry, Amany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864074/ https://www.ncbi.nlm.nih.gov/pubmed/35223890 http://dx.doi.org/10.3389/fmed.2022.770017 |
Ejemplares similares
-
Modulation of the Gut Microbiome to Improve Clinical Outcomes in Hepatocellular Carcinoma
por: Shen, Sj, et al.
Publicado: (2022) -
Critical Assessment of Whole Genome and Viral Enrichment Shotgun Metagenome on the Characterization of Stool Total Virome in Hepatocellular Carcinoma Patients
por: Zhang, Fan, et al.
Publicado: (2022) -
Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
por: Behary, Jason, et al.
Publicado: (2021) -
Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions
por: Rajapakse, Jayashi, et al.
Publicado: (2023) -
Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 −/− mouse model
por: Behary, J., et al.
Publicado: (2021)